We confirmed that ANGPTL4 upregulation plays important roles in ESCC development, and serum ANGPTL4 level may be a potential tumor marker for ESCC diagnosis and prognosis. This evidence concerns the gene ANGPTL4 and esophageal squamous cell carcinoma.